Ronnah's 340B Power Story

How the 340B Program Protects Rural Kentucky’s Healthcare Lifelines—and the Patients Who Depend on Them

How the 340B Program Protects Rural Kentucky’s Healthcare Lifelines—and the Patients Who Depend on Them After 37 years in pharmacy, Ronnah Alexander has learned that in rural communities, small decisions can have enormous consequences. For the past nine years, she has led the 340B program at a clinic in Western Kentucky, where patients often travel…

Johnson & Johnson 340B Rebate Model Threat Halted Due to Advocates Like the North Carolina Community Health Center Association.

On September 30, 2024 Johnson & Johnson (J&J) announced it was ending its plans to implement a 340B rebate model for two of its drugs, Stelara and Xarelto. The immediate halt to the rebate model was prompted by the Health Resources and Services Administration’s (HRSA) September 27 letter threatening to terminate J&J’s participation in the…

340B Could Have Saved My Mother’s Life

A 340B Program Assistant Director shares how the federal 340B program could have saved the lives of her mother and other low-income Medicaid patients. by Kelli Pardee, MBA, CPhT 340B Program Assistant Director, Great Lakes Bay Health Centers May 2024   My name is Kelli Pardee, and I am a 340B Program Assistant Director at…